Skip to main content

Oliveira Steven Michael's Form 4 filing

Benitec Biopharma Inc. (BNTC) · filed Dec 9, 2021

Accession no.
0001104659-21-148207
Filed
Dec 9, 2021
Trade date
Apr 28-Dec 9, 2021
Filing delay
225 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market purchases total $1.50M. It was filed 225 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Oliveira Steven MichaelCIK 000135862910% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 28, 2021Common Stock, par value $0,0001 per sharePPurchaseAcquired+100,000$5.45+$545,000768,123Indirect
Apr 29, 2021Common Stock, par value $0,0001 per sharePPurchaseAcquired+22,877$5.49+$125,594.73791,000Indirect
Apr 30, 2021Common Stock, par value $0,0001 per sharePPurchaseAcquired+120,000$4.18+$501,600911,000Indirect
May 3, 2021Common Stock, par value $0,0001 per sharePPurchaseAcquired+40,500$4.25+$172,125951,500Indirect
Nov 29, 2021Common Stock, par value $0,0001 per sharePPurchaseAcquired+37,947$3.18+$120,671.46989,447Indirect
Dec 9, 2021Common Stock, par value $0,0001 per sharePPurchaseAcquired+10,553$3.04+$32,081.121,000,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)